GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

GSK has shared the data behind its phase 3 liver disease win, revealing patients on linerixibat reported reductions in ...

British drugmaker GSK insisted it was “well positioned” to respond to the impact of sector-specific tariffs amid widespread ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainant ... was taken verbatim from part of the summary of product characteristics, which had been approved ...

GSK has posted a solid set of financial results in the first quarter of this year and said it is not too worried about the financial impact of potential pharma ... the five FDA product approvals ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the ...

GSK is 'well positioned' to deal with the ... tariff on all imported US goods earlier this month but exempted pharmaceutical products from those duties. But the US Government began investigations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

British drugmaker GSK insisted it was “well positioned” to respond ... Trump voiced his desire to slap tariffs on pharma products in the “not too distant future”. He previously said: “We don’t make ...